middle.news
Artrya Secures A$75M to Accelerate U.S. Rollout of Salix AI Platform
9:27am on Tuesday 9th of September, 2025 AEST
•
Healthcare
Read Story
Artrya Secures A$75M to Accelerate U.S. Rollout of Salix AI Platform
9:27am on Tuesday 9th of September, 2025 AEST
Key Points
A$75 million two-tranche placement at A$2.05 per share
Up to A$5 million share purchase plan for existing shareholders
Funds to accelerate U.S. commercial expansion and product development
Supports rollout of Salix platform after FDA clearance of Coronary Plaque module
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE